Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances narrower proposal to add GLP‑1 obesity coverage to state employee plan amid fiscal concerns
Summary
House Bill 783 would expand the state employee health plan to cover GLP‑1 medications for class 3 obesity and PCOS; the sponsor and administration disputed the likely fiscal impact during committee testimony.
House Bill 783, sponsored in committee discussion by its sponsor, would expand coverage of GLP‑1 medications in the state employee health plan to include class 3 obesity (BMI ≥40) and polycystic ovary syndrome (PCOS). The bill’s sponsor presented a map showing roughly two dozen states with some GLP‑1 coverage for weight loss and described a significantly lower fiscal estimate in the bill’s current version compared with an earlier draft.
The sponsor walked the committee through differences between fiscal notes: the original fiscal estimate was substantially higher (in the tens of millions) while the current committee amendment’s fiscal estimate was smaller, reflecting narrower eligibility. The sponsor said the expectation underlying the current fiscal…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
